185 related articles for article (PubMed ID: 22549866)
1. [Measles virus: a future therapeutic agent in oncology?].
Touchefeu Y; Schick U; Harrington KJ
Med Sci (Paris); 2012 Apr; 28(4):388-94. PubMed ID: 22549866
[TBL] [Abstract][Full Text] [Related]
2. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of oncolytic measles virus: promises and challenges.
Galanis E
Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
[TBL] [Abstract][Full Text] [Related]
4. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
[TBL] [Abstract][Full Text] [Related]
5. Use of attenuated paramyxoviruses for cancer therapy.
Lech PJ; Russell SJ
Expert Rev Vaccines; 2010 Nov; 9(11):1275-302. PubMed ID: 21087107
[TBL] [Abstract][Full Text] [Related]
6. Attenuated oncolytic measles virus strains as cancer therapeutics.
Msaouel P; Iankov ID; Dispenzieri A; Galanis E
Curr Pharm Biotechnol; 2012 Jul; 13(9):1732-41. PubMed ID: 21740361
[TBL] [Abstract][Full Text] [Related]
7. Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S; Bailey K; Fielding A
Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
[TBL] [Abstract][Full Text] [Related]
8. Potential and clinical translation of oncolytic measles viruses.
Robinson S; Galanis E
Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
[TBL] [Abstract][Full Text] [Related]
9. Measles as a potential oncolytic virus.
Fielding AK
Rev Med Virol; 2005; 15(2):135-42. PubMed ID: 15546127
[TBL] [Abstract][Full Text] [Related]
10. Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.
Weiland T; Lampe J; Essmann F; Venturelli S; Berger A; Bossow S; Berchtold S; Schulze-Osthoff K; Lauer UM; Bitzer M
Int J Cancer; 2014 Jan; 134(1):235-43. PubMed ID: 23797800
[TBL] [Abstract][Full Text] [Related]
11. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
[TBL] [Abstract][Full Text] [Related]
12. Future prospects for oncolytic therapy.
McCormick F
Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
[TBL] [Abstract][Full Text] [Related]
13. [Vesicular stomatitis virus in the fight against cancer].
Janelle V; Poliquin L; Lamarre A
Med Sci (Paris); 2013 Feb; 29(2):175-82. PubMed ID: 23452604
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic virotherapy of breast cancer.
Hartkopf AD; Fehm T; Wallwiener D; Lauer UM
Gynecol Oncol; 2011 Oct; 123(1):164-71. PubMed ID: 21764108
[TBL] [Abstract][Full Text] [Related]
15. Measles virus as an oncolytic vector platform.
Blechacz B; Russell SJ
Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591
[TBL] [Abstract][Full Text] [Related]
16. Modeling of cancer virotherapy with recombinant measles viruses.
Bajzer Z; Carr T; Josić K; Russell SJ; Dingli D
J Theor Biol; 2008 May; 252(1):109-22. PubMed ID: 18316099
[TBL] [Abstract][Full Text] [Related]
17. Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy.
Power AT; Bell JC
Gene Ther; 2008 May; 15(10):772-9. PubMed ID: 18369325
[TBL] [Abstract][Full Text] [Related]
18. ReVOLT: radiation-enhanced viral oncolytic therapy.
Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
[TBL] [Abstract][Full Text] [Related]
19. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
[TBL] [Abstract][Full Text] [Related]
20. Radiovirotherapy: principles and prospects in oncology.
Touchefeu Y; Franken P; Harrington KJ
Curr Pharm Des; 2012; 18(22):3313-20. PubMed ID: 22397732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
